Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 11, 2007, Pages 1096-1100

  van Hal, S J ^a   Muthiah, K ^a   Matthews, G ^b   Harkness, J ^a   Stark, D ^a   Cooper, D ^b   Marriott, D ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

AIDS; AIDS related mortality; Australia; HAART; Immunosuppression; Microsporidiosis

Indexed keywords

ALBENDAZOLE; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; AUSTRALIA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION RATE; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MICROSPORIDIOSIS; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; RISK REDUCTION; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; INCIDENCE; INTESTINAL DISEASES; MALE; MICROSPORIDIOSIS; MIDDLE AGED; NEW SOUTH WALES; TREATMENT OUTCOME;

EID: 34548859810     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.06.003     Document Type: Article

References (22)

1. CAESAR Co-ordinating Committee. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet 349 (1997) 1413-1421
2. Carr A., Marriott D., Field A., Vasak E., and Cooper D.A. A treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 351 (1998) 256-261
3. Conteas C.N., Berlin O.G., Speck C.E., Pandhumas S.S., Lariviere M.J., and Fu C. Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy. Am. J. Trop. Med. Hyg. 58 (1998) 555-558
4. Derouin F., and Gangneux J.P. Changing patterns of disease and treatment of opportunistic parasitic infections in patients with AIDS. Curr. Opin. Infect. Dis. 11 (1998) 711-716
5. Didier E.S. Microsporidiosis. Clin. Infect. Dis. 27 (1998) 1-8
6. Dieterich D.T., Lew E.A., Kotler D.P., Poles M.A., and Orenstein J.M. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Infect. Dis. 169 (1994) 178-183
7. Eeftinck Schattenkerk J.K.M., van Gool T., van Ketel R.J., and Bartelsman J.F. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 337 (1991) 895-898
8. Field A.S., Hing M.C., Milliken S.T., and Marriott D.J. Microsporidia in the small intestine of HIV-infected patients. A new diagnostic technique and a new species. Med. J. Aust. 158 (1993) 390-394
9. Gainzarain J.C., Canut A., Lozano M., Labora A., Carreras F., Fenoy S., Navajas R., Pieniazek N.J., da Silva A.J., and del Aguila C. Detection of Enterocytozoon bieneusi in two human immunodeficiency virus-negative patients with chronic diarrhea by polymerase chain reaction in duodenal biopsy and review. Clin. Infect. Dis. 27 (1998) 394-398
10. Hart C.A., Beeching N.J., and Duerden B. Infections in AIDS. J. Med. Microbiol. 49 (2000) 947-967
11. Kotler D.P., and Orenstein J.M. Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastrointestinal evaluation. Am. J. Gastroenterol. 89 (1994) 1998-2002
12. Kotler D.P., and Orenstein J.M. Clinical syndromes associated with microsporidiosis. In: Wittner M., and Weiss L.M. (Eds). The Microsporidia and Microsporidiosis (1999), ASM Press, Washington, D.C. 258-292
13. Kyaw T., Curry A., Edwards-Jones V., Craske J., and Mandal B.K. The prevalence of Enterocytozoon bieneusi in acquired immunodeficiency syndrome (AIDS) patients from the north west of England: 1992-1995. Br. J. Biomed. Sci. 54 (1997) 186-191
14. Miao Y.M., Awad-El-Kariem F.M., Franzen C., Ellis D.S., Muller A., Counihan H.M., Hayes P.J., and Gazzard B.G. Eradication of Cryptosporidia and Microsporidia following successful antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 25 (2000) 124-129
15. Molina J.M., Sarfati C., Beauvais B., Lemann M., Lesourd A., Ferchal F., Casin I., Lagrange P., Modigliani R., Derouin F., and Modai J. Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features. J. Infect. Dis. 167 (1993) 217-221
16. Orenstein J.M. Microsporidiosis in the acquired immunodeficiency syndrome. J. Parasitol. 77 (1991) 843-864
17. Orenstein J.M., Chiang J., Steinberg W., Smith P.D., Rotterdam H., and Kotler D.P. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: a report of 20 cases. Hum. Pathol. 21 (1990) 475-481
18. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., and Holmberg S.D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338 (1998) 853-860
19. Palella Jr. F.J., Baker R.K., Moorman A.C., Chmiel J.S., Wood K.C., Brooks J.T., Holmberg S.D., and HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J. Acquir. Immune Defic. Syndr. 43 (2006) 27-34
20. Pozio E. Highly active antiretroviral therapy and opportunistic protozoan infections. Parassitologia 46 (2004) 89-93
21. Pozio E., and Morales M.A. The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol. 21 (2005) 58-63
22. van Gool T., Snijders J., Eeftinck-Schattenkerk M., van den Bergh Weerman M.A., Bartelsman J.F., Bruins J.J., Canning E.U., and Dankert J. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J. Clin. Pathol. 46 (1993) 694-699